OrganiGram (OGI)
(Delayed Data from NSDQ)
$1.80 USD
-0.04 (-2.17%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.79 -0.01 (-0.56%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth A Momentum A VGM
Balance Sheet
Fiscal Year End for Organigram Holdings Inc falls in the month of September.
All items in Millions except Per Share data.
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 25 | 78 | 78 | 145 | 56 |
Receivables | 22 | 36 | 36 | 17 | 13 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 60 | 54 | 54 | 39 | 53 |
Other Current Assets | 8 | 7 | 7 | 5 | 5 |
Total Current Assets | 116 | 174 | 174 | 206 | 127 |
Net Property & Equipment | 73 | 204 | 204 | 186 | 184 |
Investments & Advances | 24 | 27 | 27 | 29 | 11 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 4 | 4 | 3 | 1 |
Intangibles | 8 | 44 | 44 | 13 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 221 | 454 | 454 | 437 | 324 |
Liabilities & Shareholders Equity | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 15 | 32 | 32 | 18 | 13 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 9 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 1 | 1 | 0 | 0 |
Other Current Liabilities | 2 | 10 | 10 | 2 | 0 |
Total Current Liabilities | 17 | 43 | 43 | 21 | 22 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 3 | 3 | 0 | 8 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 77 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 3 | 8 | 8 | 38 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 20 | 54 | 54 | 59 | 101 |
Shareholders Equity | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 576 | 605 | 605 | 576 | 313 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -399 | -228 | -228 | -217 | -108 |
Other Equity | 25 | 22 | 22 | 19 | 18 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 201 | 399 | 399 | 378 | 223 |
Total Liabilities & Shareholder's Equity | 221 | 454 | 454 | 437 | 324 |
Total Common Equity | 201 | 399 | 399 | 378 | 223 |
Shares Outstanding | 81.10 | 78.40 | 74.90 | 48.60 | 39.00 |
Book Value Per Share | 2.48 | 5.09 | 5.33 | 7.79 | 5.71 |
Fiscal Year End for Organigram Holdings Inc falls in the month of September.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 59 | 54 | 31 | 25 | 39 |
Receivables | 22 | 22 | 21 | 22 | 27 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 61 | 62 | 60 | 60 | 60 |
Other Current Assets | 8 | 7 | 6 | 8 | 7 |
Total Current Assets | 150 | 144 | 118 | 116 | 133 |
Net Property & Equipment | 70 | 72 | 72 | 73 | 81 |
Investments & Advances | 32 | 22 | 21 | 24 | 27 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 1 | 1 | 0 | 2 |
Intangibles | 6 | 7 | 8 | 8 | 13 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 259 | 246 | 220 | 221 | 257 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 29 | 30 | 26 | 15 | 25 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 6 | 12 | 1 | 2 | 4 |
Total Current Liabilities | 35 | 42 | 28 | 17 | 29 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 2 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 8 | 3 | 3 | 3 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 43 | 44 | 30 | 20 | 34 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 612 | 606 | 571 | 576 | 571 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -423 | -431 | -407 | -399 | -372 |
Other Equity | 27 | 27 | 26 | 25 | 24 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 216 | 201 | 189 | 201 | 222 |
Total Liabilities & Shareholder's Equity | 259 | 246 | 220 | 221 | 257 |
Total Common Equity | 216 | 201 | 189 | 201 | 222 |
Shares Outstanding | 103.80 | 103.30 | 94.00 | 81.10 | 80.50 |
Book Value Per Share | 2.08 | 1.95 | 2.01 | 2.48 | 2.76 |